This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitaet Basel. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Jean Christophe Peter: Innovator in Monoclonal Antibodies
Introduction
Jean Christophe Peter is a notable inventor based in Ammerschwihr, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative treatments for cachexia and related conditions.
Latest Patents
Jean Christophe Peter holds a patent for "Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases." This patent discloses monoclonal antibodies, binding fragments, and derivatives directed to the human melanocortin-4 receptor. It also includes pharmaceutical compositions and therapeutic uses for treating cachexia and related diseases.
Career Highlights
Throughout his career, Jean Christophe Peter has worked with prestigious institutions such as Universitaet Basel and Universität Basel. His research has contributed to advancements in medical treatments and therapeutic applications.
Collaborations
One of his notable collaborators is Karl Hofbauer. Their partnership has likely fostered innovative research and development in their field.
Conclusion
Jean Christophe Peter's work in monoclonal antibodies represents a significant advancement in the treatment of cachexia and related conditions. His contributions to biotechnology continue to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile